| MUC1-C induces PD-L1 and immune evasion in triple-negative breast cancer T Maeda, M Hiraki, C Jin, H Rajabi, A Tagde, M Alam, A Bouillez, X Hu, ... Cancer research 78 (1), 205-215, 2018 | 202 | 2018 |
| Isolation and characterization of a primary proximal tubular epithelial cell model from human kidney by CD10/CD13 double labeling C Van der Hauwaert, G Savary, V Gnemmi, F Glowacki, N Pottier, ... PloS one 8 (6), e66750, 2013 | 122 | 2013 |
| MUC1-C Integrates PD-L1 Induction with Repression of Immune Effectors in Non-small Cell Lung Cancer. A Bouillez, H Rajabi, C Jin, M Samur, A Tagde, M Alam, M Hiraki, ... Oncogene, 2017 | 119 | 2017 |
| MUC1 drives epithelial–mesenchymal transition in renal carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter V Gnemmi, A Bouillez, K Gaudelot, B Hémon, B Ringot, N Pottier, ... Cancer letters 346 (2), 225-236, 2014 | 92 | 2014 |
| DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells H Rajabi, A Tagde, M Alam, A Bouillez, S Pitroda, Y Suzuki, D Kufe Oncogene 35 (50), 6439-6445, 2016 | 87 | 2016 |
| MUC1-C drives MYC in multiple myeloma A Tagde, H Rajabi, A Bouillez, M Alam, R Gali, S Bailey, YT Tai, ... Blood, The Journal of the American Society of Hematology 127 (21), 2587-2597, 2016 | 85 | 2016 |
| Inhibition of MUC1-C suppresses MYC expression and attenuates malignant growth in KRAS mutant lung adenocarcinomas A Bouillez, H Rajabi, S Pitroda, C Jin, M Alam, A Kharbanda, A Tagde, ... Cancer research 76 (6), 1538-1548, 2016 | 85 | 2016 |
| MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer A Bouillez, D Adeegbe, C Jin, X Hu, A Tagde, M Alam, H Rajabi, KK Wong, ... Oncoimmunology 6 (9), e1338998, 2017 | 53 | 2017 |
| MUC1-C activates BMI1 in human cancer cells M Hiraki, T Maeda, A Bouillez, M Alam, A Tagde, K Hinohara, Y Suzuki, ... Oncogene 36 (20), 2791-2801, 2017 | 52 | 2017 |
| MUC1-C activates EZH2 expression and function in human cancer cells H Rajabi, M Hiraki, A Tagde, M Alam, A Bouillez, CL Christensen, ... Scientific Reports 7 (1), 7481, 2017 | 46 | 2017 |
| Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer M Hiraki, T Maeda, N Mehrotra, C Jin, M Alam, A Bouillez, T Hata, ... Signal transduction and targeted therapy 3 (1), 13, 2018 | 45 | 2018 |
| MUC1-C represses the Crumbs complex polarity factor CRB3 and downregulates the Hippo pathway M Alam, A Bouillez, A Tagde, R Ahmad, H Rajabi, T Maeda, M Hiraki, ... Molecular Cancer Research 14 (12), 1266-1276, 2016 | 44 | 2016 |
| MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia A Tagde, H Rajabi, D Stroopinsky, R Gali, M Alam, A Bouillez, ... Oncotarget 7 (26), 38974, 2016 | 40 | 2016 |
| MUC1-C nuclear localization drives invasiveness of renal cancer cells through a sheddase/gamma secretase dependent pathway A Bouillez, V Gnemmi, K Gaudelot, B Hemon, B Ringot, N Pottier, ... Oncotarget 5 (3), 754, 2014 | 30 | 2014 |
| Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma A Tagde, T Markert, H Rajabi, M Hiraki, M Alam, A Bouillez, D Avigan, ... Oncotarget 8 (41), 69237, 2017 | 8 | 2017 |
| Involvement of the membrane-bound mucin MUC1 in renal-clear cell carcinoma progression and identification of new therapeutic targets A Bouillez < bound method Organization. get_name_with_acronym of< Organization: TEL …, 2014 | | 2014 |
